Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients (original) (raw)
Atovaquone Suspension Compared with Aerosolized Pentamidine for Prevention ofPneumocystis cariniiPneumonia in Human Immunodeficiency Virus–Infected Subjects Intolerant of Trimethoprim or Sulfonamides
Raymond Marina
The Journal of Infectious Diseases, 1999
View PDFchevron_right
Pulmonary tolerance of prophylactic aerosolized pentamidine in human immunodeficiency virus-infected patients
Roland Landman
CHEST Journal, 1991
View PDFchevron_right
Toxic epidermal necrolysis in a patient infected with human immunodeficiency virus-2
Isabel Da Franca
Journal of the European Academy of Dermatology and Venereology, 2002
View PDFchevron_right
Tolerability of Aerosolized Versus Intravenous Pentamidine for Pneumocystis jirovecii Pneumonia Prophylaxis in Immunosuppressed Pediatric, Adolescent, and Young Adult Patients
Kelsey Brown
The Journal of Pediatric Pharmacology and Therapeutics
View PDFchevron_right
Bilateral Upper Lobe Pneumocystis carinii Pneumonia in a Patient Receiving Inhaled Pentamidine Prophylaxis
Jonathan Ilowite
Chest, 1988
View PDFchevron_right
Simkania negevensis infection among Brazilian children hospitalized with community-acquired pneumonia
Mika Paldanius
Journal of Infection, 2009
View PDFchevron_right
SystemicPenicillium marneffei infection in a German AIDS patient
Helmut Albrecht
European Journal of Clinical Microbiology & Infectious Diseases, 1996
View PDFchevron_right
Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya
T. Ouko, Evans Amukoye
East African Medical Journal, 2004
View PDFchevron_right
Clinical manifestation and initial treatment on infectious respiratory illnesses in HIV-infected patient: a case report
Wira Jaya
International Journal of Advances in Medicine, 2021
View PDFchevron_right
Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection
Stephen Morris-jones
Journal of Antimicrobial Chemotherapy, 1997
View PDFchevron_right
A 5-Year Retrospective Review of Adverse Drug Reactions and Their Risk Factors in Human Immunodeficiency Virus--Infected Patients Who Were Receiving Intravenous Pentamidine Therapy for Pneumocystis carinii Pneumonia
Betty Dong
Clinical Infectious Diseases, 1997
View PDFchevron_right
Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
martin rodriguez
Clinical Microbiology Reviews, 2004
View PDFchevron_right
Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy
S. Criton
Indian Journal of Sexually Transmitted Diseases and AIDS, 2014
View PDFchevron_right
Compliance and laboratory data predict relapse rate of pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine
Milos Opravil
Klinische Wochenschrift, 1990
View PDFchevron_right
Lung Involvement of an Infectious Disease Having Increasing Incidence
gulgun afsar
Pulmonary and critical care medicine, 2017
View PDFchevron_right
Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients
Karim TRAORE
International Journal of Infectious Diseases, 2016
View PDFchevron_right
Comparative yield of different respiratory samples for diagnosis of Pneumocystis carinii infections in HIV-seropositive and seronegative individuals in India
Bijay Mirdha
The Southeast Asian journal of tropical medicine and public health, 2000
View PDFchevron_right
Prophylaxis for Human Immunodeficiency Virus–Related Pneumocystis carinii Pneumonia
George Seage
Archives of Internal Medicine, 2002
View PDFchevron_right
Effectiveness of Twice-Weekly Pyrimethamine-Sulfadoxine as Primary Prophylaxis of Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Patients with Advanced HIV Infection
Bernhard Ruf, Norbert Suttorp
European Journal of Clinical Microbiology & Infectious Diseases, 2002
View PDFchevron_right
1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus
Juan Sebastian Beltran lopez
Annals of Internal Medicine, 1999
View PDFchevron_right
Pruritic popular eruption in a patient with human immunodeficiency virus infection
Gabriel Serrano
Journal of The European Academy of Dermatology and Venereology, 2006
View PDFchevron_right
Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia
Anthony Suffredini
CHEST Journal, 1992
View PDFchevron_right
Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole
Maria Beumont
The American Journal of Medicine, 1996
View PDFchevron_right
Blinded comparison of a direct immunofluorescent monoclonal antibody staining method and a Giemsa staining method for identification of Pneumocystis carinii in induced sputum and bronchoalveolar lavage specimens of patients infected with human immunodeficiency virus
marina sierra
Journal of Clinical Microbiology, 1990
View PDFchevron_right
International Journal of Pharmacy and Infections Therapy Research Article
Habip Gedik
International Journal of Pharmacy and Infections Therapy , 2022
View PDFchevron_right
AIDS-related Pneumocystis carinii Pneumonia in the Era of Adjunctive Steroids
Lori Bastian
American Journal of Respiratory and Critical Care Medicine, 1999
View PDFchevron_right
Pneumocystis pneumonia among HIV patients in Malaysia
Mahiran Mustafa
The Southeast Asian journal of tropical medicine and public health, 2009
View PDFchevron_right